2015-2027 Global Oral Anticoagulant Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 113 pages | ID: 2CAB4C055BFCEN
Maia Research

Abstracts

The worldwide market for Oral Anticoagulant is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Akers Biosciences
AstraZeneca
Novartis AG
Medicure
Sanofi
Eisai
GlaxoSmithKline
Eli Lilly
Pfizer


Major Types Covered
Warfarin
Dabigatran
Rivaroxaban
Others

Major Applications Covered
Thromboembolic Disease
Disseminated Intravascular Coagulation
Cardiovascular Surgery
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Oral Anticoagulant Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Oral Anticoagulant Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE ORAL ANTICOAGULANT MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL ORAL ANTICOAGULANT MARKET-SEGMENTATION BY TYPE

5.1 Warfarin
5.2 Dabigatran
5.3 Rivaroxaban
5.4 Others

6 GLOBAL ORAL ANTICOAGULANT MARKET-SEGMENTATION BY APPLICATION

6.1 Thromboembolic Disease
6.2 Disseminated Intravascular Coagulation
6.3 Cardiovascular Surgery
6.4 Others

7 GLOBAL ORAL ANTICOAGULANT MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Akers Biosciences
  8.1.1 Akers Biosciences Profile
  8.1.2 Akers Biosciences Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Akers Biosciences Product/Solution Launches and Enhancements Analysis
  8.1.4 Akers Biosciences Business Overview/Recent Development/Acquisitions
8.2 AstraZeneca
  8.2.1 AstraZeneca Profile
  8.2.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
  8.2.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.3 Novartis AG
  8.3.1 Novartis AG Profile
  8.3.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Novartis AG Product/Solution Launches and Enhancements Analysis
  8.3.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.4 Medicure
  8.4.1 Medicure Profile
  8.4.2 Medicure Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Medicure Product/Solution Launches and Enhancements Analysis
  8.4.4 Medicure Business Overview/Recent Development/Acquisitions
8.5 Sanofi
  8.5.1 Sanofi Profile
  8.5.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Sanofi Product/Solution Launches and Enhancements Analysis
  8.5.4 Sanofi Business Overview/Recent Development/Acquisitions
8.6 Eisai
  8.6.1 Eisai Profile
  8.6.2 Eisai Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Eisai Product/Solution Launches and Enhancements Analysis
  8.6.4 Eisai Business Overview/Recent Development/Acquisitions
8.7 GlaxoSmithKline
  8.7.1 GlaxoSmithKline Profile
  8.7.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
  8.7.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.8 Eli Lilly
  8.8.1 Eli Lilly Profile
  8.8.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
  8.8.4 Eli Lilly Business Overview/Recent Development/Acquisitions
8.9 Pfizer
  8.9.1 Pfizer Profile
  8.9.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.9.4 Pfizer Business Overview/Recent Development/Acquisitions

9 GLOBAL ORAL ANTICOAGULANT MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Oral Anticoagulant Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Oral Anticoagulant Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Oral Anticoagulant Production Analysis from 2015-2020
10.4 North America Oral Anticoagulant Consumption Analysis from 2015-2020
10.5 North America Oral Anticoagulant Import and Export from 2015-2020
10.6 North America Oral Anticoagulant Value, Production and Market Share by Type (2015-2020)
10.7 North America Oral Anticoagulant Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Oral Anticoagulant by Country (United States, Canada)
  10.8.1 North America Oral Anticoagulant Sales by Country (2015-2020)
  10.8.2 North America Oral Anticoagulant Consumption Value by Country (2015-2020)
10.9 North America Oral Anticoagulant Market PEST Analysis

11 EUROPE

11.1 Europe Oral Anticoagulant Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Oral Anticoagulant Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Oral Anticoagulant Production Analysis from 2015-2020
11.4 Europe Oral Anticoagulant Consumption Analysis from 2015-2020
11.5 Europe Oral Anticoagulant Import and Export from 2015-2020
11.6 Europe Oral Anticoagulant Value, Production and Market Share by Type (2015-2020)
11.7 Europe Oral Anticoagulant Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Oral Anticoagulant by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Oral Anticoagulant Sales by Country (2015-2020)
  11.8.2 Europe Oral Anticoagulant Consumption Value by Country (2015-2020)
11.9 Europe Oral Anticoagulant Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Oral Anticoagulant Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Oral Anticoagulant Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Oral Anticoagulant Production Analysis from 2015-2020
12.4 Asia-Pacific Oral Anticoagulant Consumption Analysis from 2015-2020
12.5 Asia-Pacific Oral Anticoagulant Import and Export from 2015-2020
12.6 Asia-Pacific Oral Anticoagulant Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Oral Anticoagulant Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Oral Anticoagulant by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Oral Anticoagulant Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Oral Anticoagulant Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Oral Anticoagulant Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Oral Anticoagulant Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Oral Anticoagulant Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Oral Anticoagulant Production Analysis from 2015-2020
13.4 Latin America Oral Anticoagulant Consumption Analysis from 2015-2020
13.5 Latin America Oral Anticoagulant Import and Export from 2015-2020
13.6 Latin America Oral Anticoagulant Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Oral Anticoagulant Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Oral Anticoagulant by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Oral Anticoagulant Sales by Country (2015-2020)
  13.8.2 Latin America Oral Anticoagulant Consumption Value by Country (2015-2020)
13.9 Latin America Oral Anticoagulant Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Oral Anticoagulant Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Oral Anticoagulant Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Oral Anticoagulant Production Analysis from 2015-2020
14.4 Middle East & Africa Oral Anticoagulant Consumption Analysis from 2015-2020
14.5 Middle East & Africa Oral Anticoagulant Import and Export from 2015-2020
14.6 Middle East & Africa Oral Anticoagulant Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Oral Anticoagulant Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Oral Anticoagulant by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Oral Anticoagulant Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Oral Anticoagulant Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Oral Anticoagulant Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL ORAL ANTICOAGULANT MARKET FROM 2020-2027

15.1 Future Forecast of the Global Oral Anticoagulant Market from 2020-2027 Segment by Region
15.2 Global Oral Anticoagulant Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Oral Anticoagulant Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Oral Anticoagulant Market Value ($) and Growth Rate of Oral Anticoagulant from 2015-2027
Global Oral Anticoagulant Production and Growth Rate Segment by Product Type from 2015-2027
Global Oral Anticoagulant Consumption and Growth Rate Segment by Application from 2015-2027
Figure Oral Anticoagulant Picture
Table Product Specifications of Oral Anticoagulant
Table Driving Factors for this Market
Table Industry News of Oral Anticoagulant Market
Figure Value Chain Status of Oral Anticoagulant
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Oral Anticoagulant Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Oral Anticoagulant Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Warfarin of Oral Anticoagulant
Figure Dabigatran of Oral Anticoagulant
Figure Rivaroxaban of Oral Anticoagulant
Figure Others of Oral Anticoagulant
Table Global Oral Anticoagulant Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Oral Anticoagulant Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Thromboembolic Disease of Oral Anticoagulant
Figure Disseminated Intravascular Coagulation of Oral Anticoagulant
Figure Cardiovascular Surgery of Oral Anticoagulant
Figure Others of Oral Anticoagulant
Table Global Oral Anticoagulant Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Oral Anticoagulant Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Oral Anticoagulant
Figure Online Channel of Oral Anticoagulant
Table Akers Biosciences Profile (Company Name, Plants Distribution, Sales Region)
Figure Akers Biosciences Sales and Growth Rate from 2015-2020
Figure Akers Biosciences Revenue ($) and Global Market Share from 2015-2020
Table Akers Biosciences Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis AG Sales and Growth Rate from 2015-2020
Figure Novartis AG Revenue ($) and Global Market Share from 2015-2020
Table Novartis AG Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table Medicure Profile (Company Name, Plants Distribution, Sales Region)
Figure Medicure Sales and Growth Rate from 2015-2020
Figure Medicure Revenue ($) and Global Market Share from 2015-2020
Table Medicure Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi Sales and Growth Rate from 2015-2020
Figure Sanofi Revenue ($) and Global Market Share from 2015-2020
Table Sanofi Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eisai Profile (Company Name, Plants Distribution, Sales Region)
Figure Eisai Sales and Growth Rate from 2015-2020
Figure Eisai Revenue ($) and Global Market Share from 2015-2020
Table Eisai Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly Sales and Growth Rate from 2015-2020
Figure Eli Lilly Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Oral Anticoagulant Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Oral Anticoagulant Production Value ($) by Region from 2015-2020
Table Global Oral Anticoagulant Production Value Share by Region from 2015-2020
Table Global Oral Anticoagulant Production by Region from 2015-2020
Table Global Oral Anticoagulant Consumption Value ($) by Region from 2015-2020
Table Global Oral Anticoagulant Consumption by Region from 2015-2020
Table North America Oral Anticoagulant Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Oral Anticoagulant Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Oral Anticoagulant Import and Export from 2015-2020
Table North America Oral Anticoagulant Value ($) by Type (2015-2020)
Table North America Oral Anticoagulant Production by Type (2015-2020)
Table North America Oral Anticoagulant Consumption by Application (2015-2020)
Table North America Oral Anticoagulant Consumption by Country (2015-2020)
Table North America Oral Anticoagulant Consumption Value ($) by Country (2015-2020)
Figure North America Oral Anticoagulant Market PEST Analysis
Table Europe Oral Anticoagulant Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Oral Anticoagulant Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Oral Anticoagulant Import and Export from 2015-2020
Table Europe Oral Anticoagulant Value ($) by Type (2015-2020)
Table Europe Oral Anticoagulant Production by Type (2015-2020)
Table Europe Oral Anticoagulant Consumption by Application (2015-2020)
Table Europe Oral Anticoagulant Consumption by Country (2015-2020)
Table Europe Oral Anticoagulant Consumption Value ($) by Country (2015-2020)
Figure Europe Oral Anticoagulant Market PEST Analysis
Table Asia-Pacific Oral Anticoagulant Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Oral Anticoagulant Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Oral Anticoagulant Import and Export from 2015-2020
Table Asia-Pacific Oral Anticoagulant Value ($) by Type (2015-2020)
Table Asia-Pacific Oral Anticoagulant Production by Type (2015-2020)
Table Asia-Pacific Oral Anticoagulant Consumption by Application (2015-2020)
Table Asia-Pacific Oral Anticoagulant Consumption by Country (2015-2020)
Table Asia-Pacific Oral Anticoagulant Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Oral Anticoagulant Market PEST Analysis
Table Latin America Oral Anticoagulant Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Oral Anticoagulant Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Oral Anticoagulant Import and Export from 2015-2020
Table Latin America Oral Anticoagulant Value ($) by Type (2015-2020)
Table Latin America Oral Anticoagulant Production by Type (2015-2020)
Table Latin America Oral Anticoagulant Consumption by Application (2015-2020)
Table Latin America Oral Anticoagulant Consumption by Country (2015-2020)
Table Latin America Oral Anticoagulant Consumption Value ($) by Country (2015-2020)
Figure Latin America Oral Anticoagulant Market PEST Analysis
Table Middle East & Africa Oral Anticoagulant Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Oral Anticoagulant Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Oral Anticoagulant Import and Export from 2015-2020
Table Middle East & Africa Oral Anticoagulant Value ($) by Type (2015-2020)
Table Middle East & Africa Oral Anticoagulant Production by Type (2015-2020)
Table Middle East & Africa Oral Anticoagulant Consumption by Application (2015-2020)
Table Middle East & Africa Oral Anticoagulant Consumption by Country (2015-2020)
Table Middle East & Africa Oral Anticoagulant Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Oral Anticoagulant Market PEST Analysis
Table Global Oral Anticoagulant Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Oral Anticoagulant Production and Growth Rate Forecast by Region (2020-2027)
Table Global Oral Anticoagulant Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Oral Anticoagulant Production and Growth Rate Forecast by Type (2020-2027)
Table Global Oral Anticoagulant Consumption and Growth Rate Forecast by Application (2020-2027)